Optimizing antibiotics policy in the netherlands. VI. Swab advice: No selective decontamination of IC patients on mechanical ventilation;Optimaliseren van het antibioticabeleid in nederland. VI. Swab-advies: Geen selectieve decontaminatie bij beademde patiënten op de intensive care

Nederlands Tijdschrift voor Geneeskunde

Volumn 145, Issue 8, 2001, Pages 353-357

  Bonten, M J M ^a   Kullberg, B J ^a   Filius, P M G ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; HEALTH CARE POLICY; HUMAN; INTENSIVE CARE; META ANALYSIS; NETHERLANDS; PNEUMONIA; REVIEW;

ANTIBIOTIC PROPHYLAXIS; COST-BENEFIT ANALYSIS; HUMANS; INCIDENCE; INTENSIVE CARE; META-ANALYSIS; NETHERLANDS; PNEUMONIA; RANDOMIZED CONTROLLED TRIALS; RESPIRATION, ARTIFICIAL;

EID: 0035941745     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Optimaliseren van het antibioticabeleid in Nederland. I. De Stichting Werkgroep Antibioticabeleid (SWAB)
2. Klinisch belang van selectieve decontaminatie bij patiënten op de intensive care-afdeling
3. Selectieve decontaminatie van de tractus digestivus bij beademde patiënten op een intensive care-afdeling: Meer argumenten contra dan pro
4. Selectieve darmdecontaminatie voorkomt sterfte bij intensive-carepatiënten
5. Colonization resistance
6. The effect of selective decontamination of the digestive tract on colonisation and infection rate in multiple trauma patients
7. Selective digestive decontamination in patients in intensive care
8. Influence of airway management on ventilator-associated pneumonia: Evidence from randomized trials
9. Beademingspneumonie; controversen over diagnostiek, pathogenese, therapie en preventie
10. Effectiveness of antibiotic prophylaxis in critically ill adult patients
11. Selective decontamination on the digestive tract in surgical patients
12. Effectiveness and cost of selective decontamination of the digestive tract in critically ill intubated patients
13. Selective decontamination of the digestive tract in neurosurgical intensive care unit patients: A double-blind, randomized, placebo-controlled study
14. Randomized, controlled trial of selective digestive decontamination in 600 mechanically ventilated patients in a multidisciplinary intensive care unit
15. Changing bacterial ecology during a five-year period of selective intestinal decontamination
16. Double-blind study of selective decontamination of the digestive tract in intensive care
17. Discordance between meta-analyses and large-scale randomized, controlled trials. Examples from the management of acute myocardial infarction
18. Intestinal decontamination in a polyvalent ICU. A double-blind study
19. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial
20. Effectiveness of antibiotic prophylaxis in critically ill patients. Distinction must be made between tracheal inflammation and pneumonia
21. Antibiotic prophylaxis in intensive care units: Meta-analyses versus clinical practice
22. Antibiotics for preventing respiratory tract infections in adults receiving intensive care
23. Effects of intravenous magnesium in suspected acute myocardial infarction: Overview of randomised trials
24. 4 (Fourth International Study of Infarct Survival) Collaborative Group
25. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation
26. Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses